YOUR BUSINESS AUTHORITY
Springfield, MO
St. Louis biotech startup Arch Oncology raised $105 million in a funding round.
The round was led by Eventide Asset Management, Cowen Healthcare Investments and 3x5 Partners.
Arch Oncology is developing biologic therapies to treat patients with tumors and hematologic malignancies.
Read more from the St. Louis Business Journal.
The Republic School District is on track to open its Intermediate School for fifth- and sixth-grade students for the 2025-26 academic year.
Legacy Bank president exits amid investigation into 'employee-related allegations'
Chick N Max plans Springfield debut
Executive director hired at The Victim Center
Biblical history attraction planned at former Andy Williams theater
Developer seeks approval of C-Street project, including Missouri Hotel renovation
Photo Gallery: New Fire in the Hole debuts at Silver Dollar City